Purchasing for quality: the providers' view. Purchasing care for patients with acute myocardial infarction.
Open Access
- 1 March 1992
- journal article
- research article
- Published by BMJ in Quality and Safety in Health Care
- Vol. 1 (1) , 68-73
- https://doi.org/10.1136/qshc.1.1.68
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Differences in the Use of Procedures between Women and Men Hospitalized for Coronary Heart DiseaseNew England Journal of Medicine, 1991
- SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.BMJ, 1991
- Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.Heart, 1991
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- EFFECTS OF ALTEPLASE IN ACUTE MYOCARDIAL-INFARCTION - 6-MONTH RESULTS FROM THE ASSET STUDY1990
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Role of exercise testing early after myocardial infarction in identifying candidates for coronary surgery.BMJ, 1984
- Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials.BMJ, 1982
- Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward.BMJ, 1977
- Comparison of Mobilization after Two and Nine Days in Uncomplicated Myocardial InfarctionBMJ, 1974